https://www.selleckchem.com/pr....oducts/ly3023414.htm
Using the EDS, we determined that of the 5,500 PLHIV ≥15 years on first-line ART at one facility, 4,233 (77%) had transitioned to optimized ARVs. Of the 1,267 still on legacy regimens, 459 (36%) were determined to be eligible and prioritized to switch. CONCLUSIONS This project illustrates how enhancements to the national HMIS can facilitate the use of routine patient-level data to monitor the transition to new ARVs and inform the national HIV response.OBJECTIVE To evaluate systematically the quality of the cohort studies on rheumatic
Aimer
Commentaire
Partagez
